{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:06:50Z","timestamp":1791857210419,"version":"4.3.4"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1681\/asn.2013050453","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T21:33:59Z","timestamp":1379021639000},"page":"55-64","source":"Crossref","is-referenced-by-count":218,"title":["Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome"],"prefix":"10.1681","volume":"25","author":[{"given":"Fengxiao","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Maga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla M.","family":"Nester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J. H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20230410","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-10-20230410","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome.","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R3-10-20230410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2006-939767","article-title":"Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.","volume":"32","author":"Zimmerhackl","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R4-10-20230410","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: Causes and short-term course.","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R5-10-20230410","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0030-1262886","article-title":"Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.","volume":"36","author":"Le Quintrec","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R6-10-20230410","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS.","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R7-10-20230410","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome.","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"R8-10-20230410","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome.","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"R9-10-20230410","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-10-20230410","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation.","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"R11-10-20230410","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-10-20230410","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"R13-10-20230410","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.4049\/jimmunol.1100319","article-title":"A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.","volume":"188","author":"Sartz","year":"2012","journal-title":"J Immunol"},{"key":"R14-10-20230410","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R15-10-20230410","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R16-10-20230410","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molimm.2011.11.003","article-title":"Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.","volume":"49","author":"Ermini","year":"2012","journal-title":"Mol Immunol"},{"key":"R17-10-20230410","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.","volume":"204","author":"Pickering","year":"2007","journal-title":"J Exp Med"},{"key":"R18-10-20230410","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"key":"R19-10-20230410","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"R20-10-20230410","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"R21-10-20230410","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1681\/ASN.2007010062","article-title":"Is there a shared pathophysiology for thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome?","volume":"18","author":"Desch","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R22-10-20230410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semnephrol.2012.02.007","article-title":"Endothelial cells and thrombotic microangiopathy.","volume":"32","author":"Motto","year":"2012","journal-title":"Semin Nephrol"},{"key":"R23-10-20230410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome.","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"R24-10-20230410","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"R25-10-20230410","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1657558","article-title":"Thrombomodulin structure and function.","volume":"78","author":"Sadler","year":"1997","journal-title":"Thromb Haemost"},{"key":"R26-10-20230410","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V93.10.3457.410k03_3457_3466","article-title":"Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis.","volume":"93","author":"Schuster","year":"1999","journal-title":"Blood"},{"key":"R27-10-20230410","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00001721-200306000-00014","article-title":"A K19E missense mutation in the plasminogen gene is a common cause of familial hypoplasminogenaemia.","volume":"14","author":"Tefs","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R28-10-20230410","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2006-04-017350","article-title":"Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients.","volume":"108","author":"Tefs","year":"2006","journal-title":"Blood"},{"key":"R30-10-20230410","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/hmg\/4.7.1235","article-title":"The novel acceptor splice site mutation 11396(G\u2014>A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patients.","volume":"4","author":"Schloesser","year":"1995","journal-title":"Hum Mol Genet"},{"key":"R31-10-20230410","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2010.11.006","article-title":"Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease.","volume":"127","author":"Chegeni","year":"2011","journal-title":"Thromb Res"},{"key":"R32-10-20230410","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0038-1657559","article-title":"Thrombomodulin gene variations and thromboembolic disease.","volume":"78","author":"Ohlin","year":"1997","journal-title":"Thromb Haemost"},{"key":"R33-10-20230410","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0037-1614473","article-title":"Thrombomodulin gene defects in families with thromboembolic disease\u2014a report on four families.","volume":"81","author":"Ohlin","year":"1999","journal-title":"Thromb Haemost"},{"key":"R34-10-20230410","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-013-1386-4","article-title":"Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).","volume":"462","author":"Modde","year":"2013","journal-title":"Virchows Arch"},{"key":"R35-10-20230410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa011033","article-title":"Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.","volume":"346","author":"Chandler","year":"2002","journal-title":"N Engl J Med"},{"key":"R36-10-20230410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2001-15249","article-title":"The role of coagulation and fibrinolysis in the pathogenesis of diarrhea-associated hemolytic uremic syndrome.","volume":"27","author":"Proesmans","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R37-10-20230410","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.1998.00103.x","article-title":"Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.","volume":"54","author":"Van Geet","year":"1998","journal-title":"Kidney Int"},{"key":"R38-10-20230410","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0140-6736(93)90804-P","article-title":"Successful treatment of haemolytic uraemic syndrome with recombinant tissue-type plasminogen activator.","volume":"341","author":"Kruez","year":"1993","journal-title":"Lancet"},{"key":"R39-10-20230410","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJM199209103271102","article-title":"Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome.","volume":"327","author":"Bergstein","year":"1992","journal-title":"N Engl J Med"},{"key":"R40-10-20230410","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency.","volume":"111","author":"J\u00f3zsi","year":"2008","journal-title":"Blood"},{"key":"R41-10-20230410","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"R42-10-20230410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1472-6750-12-20","article-title":"Solution-based targeted genomic enrichment for precious DNA samples.","volume":"12","author":"Shearer","year":"2012","journal-title":"BMC Biotechnol"},{"key":"R43-10-20230410","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrg2986","article-title":"Genotype and SNP calling from next-generation sequencing data.","volume":"12","author":"Nielsen","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R44-10-20230410","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/gb-2010-11-8-r86","article-title":"Galaxy: A comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.","volume":"11","author":"Goecks","year":"2010","journal-title":"Genome Biol"},{"key":"R45-10-20230410","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing.","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"R46-10-20230410","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng1890","article-title":"A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.","volume":"38","author":"Hughes","year":"2006","journal-title":"Nat Genet"},{"key":"R47-10-20230410","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1167\/iovs.09-3975","article-title":"Contribution of copy number variation in the regulation of complement activation locus to development of age-related macular degeneration.","volume":"50","author":"Schmid-Kubista","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R48-10-20230410","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2350-8-9","article-title":"Detection of subtelomere imbalance using MLPA: Validation, development of an analysis protocol, and application in a diagnostic centre.","volume":"8","author":"Ahn","year":"2007","journal-title":"BMC Med Genet"},{"key":"R49-10-20230410","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2105-9-261","article-title":"Probe-specific mixed-model approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA).","volume":"9","author":"Gonz\u00e1lez","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"R50-10-20230410","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.4049\/jimmunol.158.10.5043","article-title":"The human complement C9 gene: Identification of two mutations causing deficiency and revision of the gene structure.","volume":"158","author":"Witzel-Schl\u00f6mp","year":"1997","journal-title":"J Immunol"},{"key":"R51-10-20230410","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"R52-10-20230410","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R53-10-20230410","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"R54-10-20230410","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2007-08-106153","article-title":"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.","volume":"111","author":"St\u00e5hl","year":"2008","journal-title":"Blood"},{"key":"R55-10-20230410","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","article-title":"Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.","volume":"8","author":"Jalanko","year":"2008","journal-title":"Am J Transplant"},{"key":"R56-10-20230410","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1991.tb04480.x","article-title":"Identification of two point mutations in the von Willebrand factor gene of three families with the \u2018Normandy\u2019 variant of von Willebrand disease.","volume":"78","author":"Gaucher","year":"1991","journal-title":"Br J Haematol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201401000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:12Z","timestamp":1786130592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201401000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013050453","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}